Phase 3 Trial of Lu-177-Dotatate for Midgut Neuroendocrine Tumors
The New England journal of medicine, 2017-01, Vol.376 (2), p.125
[Peer Reviewed Journal]
ISSN: 1533-4406 ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa1607427
Full text available